Rhetoric and Science and Technology Studies
- 18 June 2020
- book chapter
- Published by Springer Nature
- p. 267-284
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Public Voices in Pharmaceutical Deliberations: Negotiating “Clinical Benefit” in the FDA’s Avastin HearingJournal of Medical Humanities, 2014
- The Eltroxin controversy: Risk and how actors construct their worldHealth, Risk & Society, 2011
- Talking Off-Label: The Role ofStasisin Transforming the Discursive Formation of Pain ScienceRhetoric Society Quarterly, 2011
- The pharmaceuticalisation of society? A framework for analysisSociology of Health & Illness, 2011
- A theory of risk colonization: The spiralling regulatory logics of societal and institutional riskEconomy and Society, 2006
- The Public Understanding of Science and Public Participation in Regulated WorldsMinerva, 2004
- The pharmaceutical industry as a political playerThe Lancet, 2002
- The status of theory and method in rhetorical criticismWestern Journal of Communication, 2001
- Critical rhetoric: Theory and praxisCommunication Monographs, 1989
- The second personaQuarterly Journal of Speech, 1970